396 related articles for article (PubMed ID: 12642605)
1. Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice.
Santiago-Raber ML; Baccala R; Haraldsson KM; Choubey D; Stewart TA; Kono DH; Theofilopoulos AN
J Exp Med; 2003 Mar; 197(6):777-88. PubMed ID: 12642605
[TBL] [Abstract][Full Text] [Related]
2. Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice.
Pau E; Chang NH; Loh C; Lajoie G; Wither JE
Clin Immunol; 2011 May; 139(2):215-27. PubMed ID: 21414847
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of lupus by genetic alteration of the interferon-alpha/beta receptor.
Kono DH; Baccala R; Theofilopoulos AN
Autoimmunity; 2003 Dec; 36(8):503-10. PubMed ID: 14984027
[TBL] [Abstract][Full Text] [Related]
4. Separation of the New Zealand Black genetic contribution to lupus from New Zealand Black determined expansions of marginal zone B and B1a cells.
Atencio S; Amano H; Izui S; Kotzin BL
J Immunol; 2004 Apr; 172(7):4159-66. PubMed ID: 15034028
[TBL] [Abstract][Full Text] [Related]
5. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
Davison LM; Jørgensen TN
Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
[TBL] [Abstract][Full Text] [Related]
6. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.
White LJ; Wang JG; Davis NL; Johnston RE
J Virol; 2001 Apr; 75(8):3706-18. PubMed ID: 11264360
[TBL] [Abstract][Full Text] [Related]
7. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha-inducible proteins are novel autoantigens in murine lupus.
Hueber W; Zeng D; Strober S; Utz PJ
Arthritis Rheum; 2004 Oct; 50(10):3239-49. PubMed ID: 15476221
[TBL] [Abstract][Full Text] [Related]
9. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice.
Jørgensen TN; Roper E; Thurman JM; Marrack P; Kotzin BL
Genes Immun; 2007 Dec; 8(8):653-62. PubMed ID: 17882225
[TBL] [Abstract][Full Text] [Related]
10. Endogenous IFN-alpha beta suppresses colony-stimulating factor (CSF)-1-stimulated macrophage DNA synthesis and mediates inhibitory effects of lipopolysaccharide and TNF-alpha.
Hamilton JA; Whitty GA; Kola I; Hertzog PJ
J Immunol; 1996 Apr; 156(7):2553-7. PubMed ID: 8786318
[TBL] [Abstract][Full Text] [Related]
11. Interferon-beta: a therapeutic for autoimmune lupus in MRL-Faslpr mice.
Schwarting A; Paul K; Tschirner S; Menke J; Hansen T; Brenner W; Kelley VR; Relle M; Galle PR
J Am Soc Nephrol; 2005 Nov; 16(11):3264-72. PubMed ID: 16221871
[TBL] [Abstract][Full Text] [Related]
12. IFN-alpha induces early lethal lupus in preautoimmune (New Zealand Black x New Zealand White) F1 but not in BALB/c mice.
Mathian A; Weinberg A; Gallegos M; Banchereau J; Koutouzov S
J Immunol; 2005 Mar; 174(5):2499-506. PubMed ID: 15728455
[TBL] [Abstract][Full Text] [Related]
13. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
14. An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential.
Hadj-Slimane R; Chelbi-Alix MK; Tovey MG; Bobé P
J Interferon Cytokine Res; 2004 Dec; 24(12):717-28. PubMed ID: 15684739
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of T cells up-regulates expression of Ifi202, an interferon-inducible lupus susceptibility gene, through activation of JNK/c-Jun pathway.
Chen J; Panchanathan R; Choubey D
Immunol Lett; 2008 Jun; 118(1):13-20. PubMed ID: 18374989
[TBL] [Abstract][Full Text] [Related]
16. Ifi202, an IFN-inducible candidate gene for lupus susceptibility in NZB/W F1 mice, is a positive regulator for NF-kappaB activation in dendritic cells.
Yamauchi M; Hashimoto M; Ichiyama K; Yoshida R; Hanada T; Muta T; Komune S; Kobayashi T; Yoshimura A
Int Immunol; 2007 Aug; 19(8):935-42. PubMed ID: 17702989
[TBL] [Abstract][Full Text] [Related]
17. Deficiency of type I IFN receptor in lupus-prone New Zealand mixed 2328 mice decreases dendritic cell numbers and activation and protects from disease.
Agrawal H; Jacob N; Carreras E; Bajana S; Putterman C; Turner S; Neas B; Mathian A; Koss MN; Stohl W; Kovats S; Jacob CO
J Immunol; 2009 Nov; 183(9):6021-9. PubMed ID: 19812195
[TBL] [Abstract][Full Text] [Related]
18. Interferon-γ-dependent inhibition of B cell activation by bone marrow-derived mesenchymal stem cells in a murine model of systemic lupus erythematosus.
Schena F; Gambini C; Gregorio A; Mosconi M; Reverberi D; Gattorno M; Casazza S; Uccelli A; Moretta L; Martini A; Traggiai E
Arthritis Rheum; 2010 Sep; 62(9):2776-86. PubMed ID: 20496367
[TBL] [Abstract][Full Text] [Related]
19. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes.
Auerbuch V; Brockstedt DG; Meyer-Morse N; O'Riordan M; Portnoy DA
J Exp Med; 2004 Aug; 200(4):527-33. PubMed ID: 15302899
[TBL] [Abstract][Full Text] [Related]
20. Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow.
Lian ZX; Kikuchi K; Yang GX; Ansari AA; Ikehara S; Gershwin ME
J Immunol; 2004 Oct; 173(8):5283-9. PubMed ID: 15470074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
